Toxicology and Epidemiology of Arsenic and its Compounds

Arsenic: Environmental Chemistry, Health Threats and Waste Treatment

Volumn , Issue , 2009, Pages 237-275

  Hughes, Michael F ^a   Thomas, David J ^a   Kenyon, Elaina M ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Arsenic biotransformation; Dermal absorption of inorganic arsenic; Effects of arsenic exposure; Inorganic arsenic recognized as human carcinogen by regulatory organizations; Oxidative stress in damage of proteins, lipids, RNA, and deoxyribonucleic acid (DNA); Placental transfer and distribution in the fetus; Toxicology and epidemiology of arsenic and its compounds

Indexed keywords

EID: 79954506443     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470741122.ch4     Document Type: Chapter

References (238)

1. Abernathy, C.O., Dooley, I.S., Taft, J. and Orme-Zavaleta, J. (2000) Arsenic: moving towards a regulation, in Toxicology and Risk Assessment (eds H. Salem and E.J. Olagos), Taylor & Francis, Philadelphia, PA, pp. 211-22.
2. Abernathy, C.O., Thomas, D.J. and Calderon, R.L. (2003) Health effects and risk assessment of arsenic. Journal of Nutrition, 133(5, Suppl 2), 1536S-38S.
3. Agency for Toxic Substances and Disease Registry (ATSDR) (2007) Toxicological Profile for Arsenic, U.S. Department of Health and Human Services.
4. Ahmad, S.A., Salim Ullah Sayed, M.H., Barua, S. et al. (2001) Arsenic in drinking water and pregnancy outcomes. Environmental Health Perspectives, 109(6), 629-31.
5. Alexander, J. and Aaseth, J. (1985) Excretion of arsenic in rat bile: A role of complexing ligands containing sulphur and selenium. Nutrition Research, 5(Suppl 1), S-515-S-519.
6. Antman, K.H. (2001) Introduction: the history of arsenic trioxide in cancer therapy. Oncologist, 6(Suppl 2), 1-2.
7. Aposhian, H.V. (1989) Biochemical toxicology of arsenic, in Reviews of Biochemical Toxicology (eds E. Hodgson, J.R. Bend and R.M. Philpot), Elsevier, Amsterdam, pp. 265-99.
8. Arnold, L.L., Eldan, M., Nyska, A. et al. (2006) Dimethylarsinic acid: results of chronic toxicity/oncogenicity studies in F344 rats and in B6C3F1 mice. Toxicology, 223(1-2), 82-100.
9. Arnold, L.L., Eldan, M., Van Gemert, M. et al. (2003) Chronic studies evaluating the carcinogenicity of monomethy-larsonic acid in rats and mice. Toxicology, 190(3), 197-219.
10. Basu, A., Mahata, J., Gupta, S. and Giri, A.K. (2001) Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutation Research-Reviews in Mutation Research, 488(2), 171-94.
11. Beck, B.D., Slayton, T.M., Farr, C.H. et al. (2002) Systemic uptake of inhaled arsenic in rabbits. Human and Experimental Toxicology, 21(4), 205-15.
12. Belluck, D.A., Benjamin, S.L., Baveye, P. et al. (2003) Widespread arsenic contamination of soils in residential areas and public spaces: an emerging regulatory or medical crisis?. International Journal of Toxicology, 22(2), 109-28.
13. Bollinger, C.T., van Zijl, P. and Louw, J.A. (1992) Multiple organ failure with the adult respiratory distress syndrome in homicidal arsenic poisoning. Respiration, 59, 57-61.
14. Braman, R.S. and Foreback, C.C. (1973) Methylated forms of arsenic in the environment. Science, 182(4118), 1247-49.
15. Bronstein, A.C., Spyker, D.A., Cantilena, L.R., Jr. et al. (2007) Jr. 2006 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS). Clinical Toxicology, 45(8), 815-917.
16. Buchet, J.P. and Lauwerys, R. (1985) Study of inorganic arsenic methylation by rat liver in vitro: Relevance for the interpretation of observations in man. Archives of Toxicology, 57(2), 125-29.
17. Buchet, J.P. and Lauwerys, R. (1988) Role of thiols in the in-vitro methylation of inorganic arsenic by rat liver cytosol. Biochemical Pharmacology, 37(16), 3149-53.
18. Buchet, J.P., Lauwerys, R. and Roels, H. (1981a) Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. International Archives of Occupational and Environmental Health, 48(1), 71-79.
19. Buchet, J.P., Lauwerys, R. and Roels, H. (1981b) Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. International Archives of Occupational and Environmental Health, 48(2), 111-18.
20. Burns, F.J., Uddin, A.N., Wu, F. et al. (2004) Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study. Environmental Health Perspectives, 112(5), 599-603.
21. Carter, D.E., Aposhian, H.V. and Gandolfi, A.J. (2003) The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicology and Applied Pharmacology, 193(3), 309-34.
22. Chakraborti, D., Sengupta, M.K., Rahman, M.M. et al. (2004) Groundwater arsenic contamination and its health effects in the Ganga-Meghna-Brahmaputra plain. Journal of Environmental Monitoring, 6(6), 74.-83N.
23. Challenger, F. (1945) Biological methylation. Chemical Reviews, 36(3), 315-61.
24. Challenger, F. (1951) Biological methylation. Advances in Enzymology and Related Subjects of Biochemistry, 12, 429-91.
25. Challenger, F., Higginbottom, C. and Ellis, L. (1933) The formation of organo-metalloidal compounds by microorganisms. Part I. Trimethylarsine and dimethylarsine. Journal of the Chemical Society, 95-101.
26. Chasteen, T.G., Wiggli, M. and Bentley, R. (2002) Of garlic, mice and Gmelin: The odor of trimethylarsine. Applied Organometallic Chemistry, 16(6), 281-86.
27. Chattopadhyay, S., Bhaumik, S., Nag Chaudhury, A. and Das Gupta, S. (2002) Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicology Letters, 128(1-3), 73-84.
28. Chen, C.-J., Chiou, H.-Y., Chiang, M.-H. et al. (1996) Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arteriosclerosis, Thrombosis, and Vascular Biology, 16(4), 504-10.
29. Chen, C.-J., Hsueh, Y.-M., Lai, M.-S. et al. (1995) Increased prevalence of hypertension and long-term arsenic exposure. Hypertension, 25(1), 53-60.
30. Chen, C.-J., Wang, S.-L., Chiou, J.-M. et al. (2007) Arsenic and diabetes and hypertension in human populations: A review. Toxicology and Applied Pharmacology, 222(3), 298-304.
31. Chowdhury, U.K., Zakharyan, R.A., Hernandez, A. et al. (2006) Glutathione-S-transferase-omega (MMA(V) reductase) knockout mice: Enzyme and arsenic species concentrations in tissues after arsenate administration. Toxicology and Applied Pharmacology, 216(3), 446-57.
32. Cohen, S.M., Arnold, L.L., Eldan, M. et al. (2006) Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Critical Reviews in Toxicology, 36(2), 99-133.
33. Collecchi, P., Esposito, M. and Brera, S. (1986) The distribution of arsenic and cobalt in patients with laryngeal carcinoma. Journal of Applied Toxicology, 6(4), 287-89.
34. Concha, G., Vogler, G., Lezcano, D. et al. (1998a) Exposure to inorganic arsenic metabolites during early human development. Toxicological Sciences, 44(2), 185-90.
35. Concha, G., Vogler, G., Nermell, B. and Vahter, M. (1998b) Low-level arsenic excretion in breast milk of native Andean women exposed to high levels of arsenic in the drinking water. International Archives of Occupational and Environmental Health, 71(1), 42-46.
36. Crecelius, E.A. (1977) Changes in the chemical speciation of arsenic following ingestion by man. Environmental Health Perspectives, 19, 147-50.
37. Csanaky, I. and Gregus, Z. (2002) Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolites. Comparative Biochemistry and Physiology C-Toxicology and Pharmacology, 131(3), 355-65.
38. Csanaky, I. and Gregus, Z. (2005) Role of glutathione in reduction of arsenate and of γ-glutamyltranspeptidase in disposition of arsenite in rats. Toxicology, 207(1), 91-104.
39. Cui, X., Kobayashi, Y., Hayakawa, T. and Hirano, S. (2004) Arsenic speciation in bile and urine following oral and intravenous exposure to inorganic and organic arsenics in rats. Toxicological Sciences, 82(2), 478-87.
40. Cullen, W.R., McBride, B.C. and Reglinski, J. (1984a) The reduction of trimethylarsine oxide to trimethylarsine by thiols: a mechanistic model for the biological reduction of arsenicals. Journal of Inorganic Biochemistry, 21(1), 45-60.
41. Cullen, W.R., McBride, B.C. and Reglinski, J. (1984b) The reaction of methylarsenicals with thiols: Some biological implications. Journal of Inorganic Biochemistry, 21(3), 179-93.
42. Cuzick, J., Sasieni, P. and Evans, S. (1992) Ingested arsenic, keratoses, and bladder cancer. American Journal of Epidemiology, 136(4), 417-21.
43. Dang, H.S., Jaiswal, D.D. and Somasundaram, S. (1983) Distribution of arsenic in human tissues and milk. Science of the Total Environment, 29(1-2), 171-75.
44. Davis, A., Ruby, M.V. and Bergstrom, P.D. (1992) Bioavailability of arsenic and lead in soils from the Butte, Montana, mining district. Environmental Science and Technology, 26(3), 461-68.
45. de Wolff, F.A. and Edelbroek, P.M. (1994) Neurotoxicity of arsenic and its compounds, in Handbook of Clinical Neurology: Intoxications of the Nervous System, Part I (ed. F.A. de Wolff), Elsevier, Amsterdam, pp. 283-91.
46. Del Razo, L.M., Quintanilla-Vega, B., Brambila-Colombres, E. et al. (2001a) Stress proteins induced by arsenic. Toxicology and Applied Pharmacology, 177(2), 132-48.
47. Del Razo, L.M., Styblo, M., Cullen, W.R. and Thomas, D.J. (2001b) Determination of trivalent methylated arsenicals in biological matrices. Toxicology and Applied Pharmacology, 174(3), 282-93.
48. Delnomdedieu, M., Basti, M.M., Otvos, J.D. and Thomas, D.J. (1993) Transfer of arsenite from glutathione to dithiols: a model of interaction. Chemical Research in Toxicology, 6(5), 598-602.
49. Delnomdedieu, M., Basti, M.M., Otvos, J.D. and Thomas, D.J. (1994a) Reduction and binding of arsenate and dimethy-larsinate by glutathione: a magnetic resonance study. Chemico-Biological Interactions, 90(2), 139-55.
50. Delnomdedieu, M., Basti, M.M., Styblo, M. et al. (1994b) Complexation of arsenic species in rabbit erythrocytes. Chemical Research in Toxicology, 7(5), 621-27.
51. Desesso, J.M. (2001) Teratogen update: inorganic arsenic. Teratology, 64(3), 170-73.
52. Desesso, J.M., Jacobson, C.F., Scialli, A.R. et al. (1998) An assessment of the developmental toxicity of inorganic arsenic. Reproductive Toxicology, 12(4), 385-433.
53. Devesa, V., Adair, B.M., Liu, J. et al. (2006) Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite. Toxicology, 224(1-2), 147-55.
54. Dixon, H.B.F. (1997) The biochemical action of arsonic acids especially as phosphate analogues. Advances in Inorganic Chemistry, 44, 191-227.
55. Drobná, Z., Waters, S.B., Devesa, V. et al. (2005) Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. Toxicology and Applied Pharmacology, 207(2), 147-59.
56. Drobná, Z., Xing, W., Thomas, D.J. and Styblo, M. (2006) shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells. Chemical Research in Toxicology, 19(7), 894-98.
57. Ellenhorn, M.J. (1997) Arsenic, Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning, 2nd edn, Williams and Wilkins, Baltimore, MD, pp. 1538-42.
58. Enterline, P.E., Henderson, V.L. and Marsh, G.M. (1987) Exposure to arsenic and respiratory cancer: a reanalysis. American Journal of Epidemiology, 125(6), 929-38.
59. Feldman, R.G., Niles, C.A. and Kelly-Hayes, M. (1979) Peripheral neuropathy in arsenic smelter workers. Neurology, 29(7), 939-44.
60. Ferreccio, C., Gonzales, C., Milosavjlevic, V. et al. (2000) Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology, 11(6), 673-79.
61. Fomenko, D.E., Xing, W., Thomas, D.J. and Gladyshev, V.N. (2007) Large-scale identification of catalytic redox-active cysteines by detecting sporadic cysteine/selenocysteine pairs in homologous sequences. Science, 315, 387-89.
62. Freeman, G.B., Johnson, J.D., Killinger, J.M. et al. (1993) Bioavailability of arsenic in soil impacted by smelter activities following oral administration in rabbits. Fundamental and Applied Toxicology, 21(1), 83-88.
63. Freeman, G.B., Schoof, R.A., Ruby, M.V. et al. (1995) Bioavailability of arsenic in soil and house dust impacted by smelter activities following oral administration in cynomolgus monkeys. Fundamental and Applied Toxicology, 28(2), 215-22.
64. Gerhardsson, L., Dahlgren, E., Eriksson, A. et al. (1988) Fatal arsenic poisoning-A case report. Scandinavian Journal of Work, Environment and Health, 14(2), 130-33.
65. Germolec, D.R., Spalding, J., Boorman, G.A. et al. (1997) Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutation Research-Reviews in Mutation Research, 386(3), 209-18.
66. Germolec, D.R., Yoshida, T., Gaido, K. et al. (1996) Arsenic induces overexpression of growth factors in human keratinocytes. Toxicology and Applied Pharmacology, 141(1), 308-18.
67. Ginsburg, J.M. and Lotspeich, W.D. (1963) Interrelations of arsenate and phosphate in the dog kidney. American Journal of Physiology, 205(4), 707-14.
68. Gonzalez, M.J., Aguilar, M.V. and Para, M.C.M. (1995) Gastrointestinal absorption of inorganic arsenic (V): the effect of concentration and interactions with phosphate and dichromate. Veterinary and Human Toxicology, 37(2), 131-36.
69. Gosio, B. (1892) Action of microphytes on solid compounds of arsenic: a recapitulation. Science, 19, 104-6.
70. Gregus, Z. and Nemeti, B. (2002) Purine nucleoside phosphorylase as a cytosolic arsenate reductase. Toxicological Sciences, 70(1), 13-19.
71. Gregus, Z. and Nemeti, B. (2005) The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase works as an arsenate reductase in human red blood cells and rat liver cytosol. Toxicological Sciences, 85(2), 859-69.
72. Groen, K., Vaessen, H.A., Kliest, J.J. et al. (1994) Bioavailability of inorganic arsenic from bog ore-containing soil in the dog. Environmental Health Perspectives, 102(2), 182-84.
73. Guha Mazumder, D.N. (2005) Effect of chronic intake of arsenic-contaminated water on liver. Toxicology and Applied Pharmacology, 206(2), 169-75.
74. Gyurasics, A., Varga, F. and Gregus, Z. (1991) Glutathione-dependent biliary excretion of arsenic. Biochemical Pharmacology, 42(3), 465-68.
75. Hakala, E. and Pyy, L. (1995) Assessment of exposure to inorganic arsenic by determining the arsenic species excreted in urine. Toxicology Letters, 77(1-3), 249-58.
76. Hall, M., Gamble, M., Slavkovich, V. et al. (2007) Determinants of arsenic metabolism: Blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environmental Health Perspectives, 115 (10), 1503-9.
77. Hartwig, A., Groblinghoff, U.D., Beyersmann, D. et al. (1997) Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis, 18(2), 399-405.
78. Hayakawa, T., Kobayashi, Y., Cui, X. and Hirano, S. (2005) A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Archives of Toxicology, 79(4), 183-91.
79. Hei, T.K., Liu, S.U.X. and Waldren, C. (1998) Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America, 95(14), 8103-7.
80. Hirata, M., Mohri, T., Hisanaga, A. and Ishinishi, N. (1989) Conversion of arsenite and arsenate to methylarsenic and dimethylarsenic compounds by homogenates prepared from livers and kidneys of rats and mice. Applied Organometallic Chemistry, 3(4), 335-41.
81. Hood, R.D., Vedel-Macrander, G.C. and Zaworotko, M.J. (1987) Distribution, metabolism, and fetal uptake of pen-tavalent arsenic in pregnant mice following oral or intraperitoneal administration. Teratology, 35(1), 19-25.
82. Hood, R.D., Vedel, G.C., Zaworotko, M.J. et al. (1988) Uptake, distribution, and metabolism of trivalent arsenic in the pregnant mouse. Journal of Toxicology and Environmental Health, 25(4), 423-34.
83. Hopenhayn-Rich, C., Browning, S.R., Hertz-Picciotto, I. et al. (2000) Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environmental Health Perspectives, 108(7), 667-73.
84. Hopenhayn, C., Huang, B., Christian, J. et al. (2003) Profile of urinary arsenic metabolites during pregnancy. Environmental Health Perspectives , 111(16), 1888-91.
85. Hsueh, Y.-M., Cheng, G.-S., Wu, M.-M. et al. (1995) Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. British Journal of Cancer, 71(1), 109-14.
86. Hu, Y., Su, L. and Snow, E.T. (1998) Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes. Mutation Research-DNA Repair, 408(3), 203-18.
87. Huang, C., Ke, Q., Costa, M. and Shi, X. (2004) Molecular mechanisms of arsenic carcinogenesis. Molecular and Cellular Biochemistry, 255(1-2), 57-66.
88. Huang, C., Li, J., Ding, M. et al. (2001) Arsenic-induced NFB transactivation through Erks-and JNKs-dependent pathways in mouse epidermal JB6 cells. Molecular and Cellular Biochemistry, 222(1-2), 29-34.
89. Huang, C., Ma, W.-Y., Li, J. et al. (1999a) Requirement of Erk, but not JNK, for arsenite-induced cell transformation. Journal of Biological Chemistry, 274(21), 14595-601.
90. Huang, C., Ma, W.-Y., Li, L. and Dong, Z. (1999b) Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway. Cancer Research, 59(13), 3053-58.
91. Huet, P.M., Guillaume, E. and Cote, J. (1975) Noncirrhotic presinusoidal portal hypertension associated with chronic arsenical intoxication. Gastroenterology, 68(5), 1270-77.
92. Hughes, M.F. (2002) Arsenic toxicity and potential mechanisms of action. Toxicology Letters, 133(1), 1-16.
93. Hughes, M.F. (2006) Biomarkers of exposure: A case study with inorganic arsenic. Environmental Health Perspectives, 114(11), 1790-96.
94. Hughes, M.F. and Kitchin, K.T. (2006) Arsenic, oxidative stress and carcinogenesis, in Oxidative Stress, Disease and Cancer (ed. K.K. Singh), Imperial College Press, London, pp. 825-50.
95. Hughes, M.F., Kenyon, E.M., Edwards, B.C. et al. (1999) Strain-dependent disposition of inorganic arsenic in the mouse. Toxicology, 137(2), 95-108.
96. Hughes, M.F., Kenyon, E.M., Edwards, B.C. et al. (2003) Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate. Toxicology and Applied Pharmacology, 191(3), 202-10.
97. Hughes, M.F., Menache, M. and Thompson, D.J. (1994) Dose-dependent disposition of sodium arsenate in mice following acute oral exposure. Fundamental and Applied Toxicology, 22(1), 80-89.
98. Hutchinson, J. (1895) Diet and therapeutics. Archives of Surgery, 6, 389-95.
99. Hwang, Y.-H., Bornschein, R.L., Grote, J. et al. (1997) Environmental arsenic exposure of children around a former copper smelter site. Environmental Research, 72(1), 72-81.
100. Ibrahim, D., Froberg, B., Wolf, A. and Rusyniak, D.E. (2006) Heavy metal poisoning: Clinical presentations and pathophysiology. Clinics in Laboratory Medicine, 26(1), 67-97.
101. Jin, Y., Xi, S., Li, X. et al. (2006) Arsenic speciation transported through the placenta from mother mice to their newborn pups. Environmental Research, 101(3), 349-55.
102. Kala, S.V., Neely, M.W., Kala, G. et al. (2000) The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. Journal ofBiological Chemistry, 275(43), 33404-8.
103. Kato, K., Hayashi, H., Hasegawa, A. et al. (1994) DNA damage induced in cultured human alveolar (L-132) cells by exposure to dimethylarsinic acid. Environmental Health Perspectives, 102(Suppl 3), 285-88.
104. Katz, S.A. and Salem, H. (2005) Chemistry and toxicology of building timbers pressure-treated with chromated copper arsenate: a review. Journal of Applied Toxicology, 25(1), 1-7.
105. Kenney, L.J. and Kaplan, J.H. (1988) Arsenate substitutes for phosphate in the human red cell sodium pump and anion exchanger. Journal of Biological Chemistry, 263(17), 7954-60.
106. Kenyon, E.M., Del Razo, L.M. and Hughes, M.F. (2005a) Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in mice following acute oral administration of arsenate. Toxicological Sciences, 85(1), 468-75.
107. Kenyon, E.M., Del Razo, L.M., Hughes, M.F. and Kitchin, K.T. (2005b) An integrated pharmacokinetic and pharmacodynamic study of arsenite action: 2. Heme oxygenase induction in mice. Toxicology, 206(3), 389-401.
108. Kenyon, E.M., Hughes, M.F., Adair, B. et al. (2008) Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57Bl/6 mice following subchronic exposure to arsenate (AsV) in drinking water. Toxicology and Applied Pharmacology, 232(3), 448-55.
109. Kenyon, E.M., Hughes, M.F. and Levander, O.A. (1997) Influence of dietary selenium on the disposition of arsenate in the female B6C3F1 mouse. Journal of Toxicology and Environmental Health-Part A, 51(3), 279-99.
110. Kessel, M., Liu, S.X., Xu, A. et al. (2002) Arsenic induces oxidative DNA damage in mammalian cells. Molecular and Cellular Biochemistry, 234-235, 301-8.
111. Kitchin, K.T. (2001) Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicology and Applied Pharmacology, 172(3), 249-61.
112. Klaassen, C.D. (1974) Biliary excretion of arsenic in rats, rabbits, and dogs. Toxicology and Applied Pharmacology, 29(3), 447-57.
113. Klimecki, W.T. and Carter, D.E. (1995) Arsine toxicity: chemical and mechanistic implications. Journal of Toxicology and Environmental Health, 46(4), 399-409.
114. Kwok, R.K., Mendola, P., Liu, Z.Y. et al. (2007) Drinking water arsenic exposure and blood pressure in healthy women of reproductive age in Inner Mongolia, China. Toxicology and Applied Pharmacology, 222(3), 337-43.
115. Lai, M.-S., Hsueh, Y.-M., Chen, C.-J. et al. (1994) Ingested inorganic arsenic and prevalence of diabetes mellitus. American Journal ofEpidemiology, 139(5), 484-92.
116. Le, X.C., Lu, X. and Li, X.-F. (2004) Arsenic speciation. Analytical Chemistry, 76(1), 26.-33A.
117. Le, X.C., Ma, M., Lu, X. et al. (2000) Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environmental Health Perspectives, 108(11), 1015-18.
118. Lee, E. (1999) A physiologically based pharmacokinetic model for the ingestion of arsenic in humans. Dissertation in Environmental Toxicology, University of California at Irvine.
119. Lee-Feldstein, A. (1986) Cumulative exposure to arsenic and its relationship to respiratory cancer among copper smelter employees. Journal of Occupational Medicine, 28(4), 296-302.
120. Li, J.-H. and Rossman, T.G. (1989) Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Molecular Toxicology, 2(1), 1-9.
121. Li, J.-H. and Rossman, T.G. (1991) Comutagenesis of sodium arsenite with ultraviolet radiation in Chinese hamster V79 cells. Biology of Metals, 4(4), 197-200.
122. Li, J., Waters, S.B., Drobna, Z. et al. (2005) Arsenic (+3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype. Toxicology and Applied Pharmacology, 204(2), 164-69.
123. Lin, S., Del Razo, L.M., Styblo, M. et al. (2001) Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chemical Research in Toxicology, 14(3), 305-11.
124. Lin, S., Shi, Q., Brent Nix, F. et al. (2002) A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol. Journal of Biological Chemistry, 277(13), 10795-803.
125. Lindgren, A., Danielsson, B.R.G., Dencker, L. and Vahter, M. (1984) Embryotoxicity of arsenite and arsenate: Distribution in pregnant mice and monkeys and effects on embryonic cells in vitro. Acta Pharmacologica et Toxicologica, 54(4), 311-20.
126. 74As-arsenite or-arsenate. Acta Pharmacologica et Toxicologica, 51(3), 253-65.
127. Liu, J., Zheng, B., Aposhian, H.V. et al. (2002) Chronic arsenic poisoning from burning high-arsenic-containing coal in Guizhou, China. Environmental Health Perspectives, 110(2), 119-22.
128. Lowney, Y.W., Ruby, M.V., Wester, R.C. et al. (2005) Percutaneous absorption of arsenic from environmental media. Toxicology and Industrial Health, 21(1-2), 1-14.
129. Lowney, Y.W., Wester, R.C., Schoof, R.A. et al. (2007) Dermal absorption of arsenic from soils as measured in the rhesus monkey. Toxicological Sciences, 100(2), 381-92.
130. Lu, M., Wang, H., Li, X.-F. et al. (2004) Evidence of hemoglobin binding to arsenic as a basis for the accumulation of arsenic in rat blood. Chemical Research in Toxicology, 17(12), 1733-42.
131. Lu, M., Wang, H., Li, X.-F. et al. (2007) Binding of dimethylarsinous acid to Cys-13α of rat hemoglobin is responsible for the retention of arsenic in rat blood. Chemical Research in Toxicology, 20(1), 27-37.
132. Lugo, G., Cassady, G. and Palmisano, P. (1969) Acute maternal arsenic intoxication with neonatal death. American Journal of Diseases of Children, 117(3), 328-30.
133. Maloney, M.E. (1996) Arsenic in dermatology. Dermatologic Surgery, 22(3), 301-4.
134. Marafante, E., Bertolero, F. and Edel, J. (1982) Intracellular interaction and biotransformation of arsenite in rats and rabbits. Science of the Total Environment, 24(1), 27-39.
135. Marafante, E. and Vahter, M. (1987) Solubility, retention, and metabolism of intratracheally and orally administered inorganic arsenic compounds in the hamster. Environmental Research, 42(1), 72-82.
136. Marafante, E., Vahter, M. and Envall, J. (1985) The role of the methylation in the detoxication of arsenate in the rabbit. Chemico-Biological Interactions, 56(2-3), 225-38.
137. Mass, M.J. and Wang, L. (1997) Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutation Research-Reviews in Mutation Research, 386(3), 263-77.
138. Mazumder, D.N.G., Steinmaus, C., Bhattacharya, P. et al. (2005) Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology, 16(6), 760-65.
139. Meharg, A.A. (2005) Venomous Earth: How Arsenic Caused the World's Worst Mass Poisoning, Macmillan, New York, 192.
140. Narang, A.P. and Datta, D.V. (1983) Brain arsenic concentrations in fulminant hepatitis. The Journal of the Association of Physicians of India, 31(8), 518-19.
141. Naranmandura, H., Suzuki, N. and Suzuki, K.T. (2006) Trivalent arsenicals are bound to proteins during reductive methylation. Chemical Research in Toxicology, 19(8), 1010-18.
142. National Research Council (NRC) (1977) Arsenic, National Research Council, National Academy of Sciences, Washington, DC.
143. National Research Council (NRC) (1999) Arsenic in Drinking Water, National Research Council, National Academy of Sciences, Washington, DC.
144. National Research Council (NRC) (2001) Arsenic in Drinking Water, 2001 Update, National Research Council, National Academy of Sciences, Washington, DC.
145. Navas-Acien, A., Sharrett, A.R., Silbergeld, E.K. et al. (2005) Arsenic exposure and cardiovascular disease: A systematic review of the epidemiologic evidence. American Journal of Epidemiology, 162(11), 1037-49.
146. Navas-Acien, A., Silbergeld, E.K., Streeter, R.A. et al. (2006) Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiologic evidence. Environmental Health Perspectives, 114(5), 641-48.
147. Nemeti, B. and Gregus, Z. (2005) Reduction of arsenate to arsenite by human erythrocyte lysate and rat liver cytosol-Characterization of a glutathione-and NAD-dependent arsenate reduction linked to glycolysis. Toxicological Sciences, 85(2), 847-58.
148. Nemeti, B. and Gregus, Z. (2007) Glutathione-dependent reduction of arsenate by glycogen phosphorylase-A reaction coupled to glycogenolysis. Toxicological Sciences, 100(1), 36-43.
149. Nemeti, B., Csanaky, I. and Gregus, Z. (2003) Arsenate reduction in human erythrocytes and rats-Testing the role of purine nucleoside phosphorylase. Toxicological Sciences, 74(1), 22-31.
150. Nordstrom, D.K. (2002) Worldwide occurrences of arsenic in ground water. Science, 296(5576), 2143-44.
151. Odanaka, Y., Matano, O. and Goto, S. (1980) Biomethylation of inorganic arsenic by the rat and some laboratory animals. Bulletin of Environmental Contamination and Toxicology, 24(3), 452-59.
152. Offergelt, J.A., Roels, H., Buchet, J.P. et al. (1992) Relation between airborne arsenic trioxide and urinary excretion of inorganic arsenic and its methylated metabolites. British Journal of Industrial Medicine, 49(6), 387-93.
153. Okui, T. and Fujiwara, Y. (1986) Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells. Mutation Research, 172(1), 69-76.
154. Pershagen, G., Lind, B. and Bjorklund, N.E. (1982) Lung retention and toxicity of some inorganic arsenic compounds. Environmental Research, 29(2), 425-34.
155. Peryea, F.J. and Creger, T.L. (1994) Vertical distribution of lead and arsenic in soils contaminated with lead arsenate pesticide residues. Water, Air, and Soil Pollution, 78(3-4), 297-306.
156. Petrick, J.S., Jagadish, B., Mash, E.A. and Aposhian, H.V. (2001) Monomethylarsonous acid (MMA(III)) and arsenite: LD50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chemical Research in Toxicology, 14(6), 651-56.
157. Polissar, L., Lowry-Coble, K., Kalman, D.A. et al. (1990) Pathways of human exposure to arsenic in a community surrounding a copper smelter. Environmental Research, 53(1), 29-47.
158. Pomroy, C., Charbonneau, S.M., McCullough, R.S. and Tam, G.K.H. (1980) Human retention studies with 74As. Toxicology and Applied Pharmacology, 53(3), 550-56.
159. Rahman, M., Tondel, M., Ahmad, S.A. and Axelson, O. (1998) Diabetes mellitus associated with arsenic exposure in Bangladesh. American Journal of Epidemiology, 148(2), 198-203.
160. Raie, R.M. (1996) Regional variation in As, Cu, Hg, and Se and interaction between them. Ecotoxicology and Environmental Safety, 35(3), 248-52.
161. Ratnaike, R.N. (2003) Acute and chronic arsenic toxicity. Postgraduate Medical Journal, 79(933), 391-96.
162. Roberts, S.M., Weimar, W.R., Vinson, J.R.T. et al. (2002) Measurement of arsenic bioavailability in soil using a primate model. Toxicological Sciences, 67(2), 303-10.
163. Robinson, G.R., Jr., Larkins, P., Boughton, C.J., Reed, B.W. et al. (2007) Assessment of contamination from arsenical pesticide use on orchards in the Great Valley region, Virginia and West Virginia, USA. Journal of Environmental Quality, 36(3), 654-63.
164. Rodriguez, V.M., Carrizales, L., Mendoza, M.S. et al. (2002) Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicology and Teratology, 24(6), 743-50.
165. Rossman, T.G. (2003) Mechanism of arsenic carcinogenesis: an integrated approach. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 533(1-2), 37-65.
166. Rossman, T.G., Uddin, A.N., Burns, F.J. and Bosland, M.C. (2001) Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. Toxicology and Applied Pharmacology, 176(1), 64-71.
167. Schoof, R.A., Yost, L.J., Eickhoff, J. et al. (1999) A market basket survey of inorganic arsenic in food. Food and Chemical Toxicology, 37(8), 839-46.
168. Schwartz, R.A. (1997) Arsenic and the skin. International Journal of Dermatology, 36(4), 241-50.
169. Scott, N., Hatlelid, K.M., MacKenzie, N.E. and Carter, D.E. (1993) Reactions of arsenic(III) and arsenic(V) species with glutathione. Chemical Research in Toxicology, 6(1), 102-6.
170. Shannon, R.L. and Strayer, D.S. (1989) Arsenic-induced skin toxicity. Human Toxicology, 8(2), 99-104.
171. Shen, J., Wanibuchi, H., Salim, E.I. et al. (2003) Liver tumorigenicity of trimethylarsine oxide in male Fischer 344 rats-association with oxidative DNA damage and enhanced cell proliferation. Carcinogenesis, 24(11), 1827-35.
172. Shi, H., Shi, X. and Liu, K.J. (2004) Oxidative mechanism of arsenic toxicity and carcinogenesis. Molecular and Cellular Biochemistry, 255(1-2), 67-78.
173. Shiobara, Y., Ogra, Y. and Suzuki, K.T. (2001) Animal species difference in the uptake of dimethylarsinous acid (DMA(III)) by red blood cells. Chemical Research in Toxicology, 14(10), 1446-52.
174. Simeonova, P.P., Wang, S., Toriuma, W. et al. (2000) Arsenic mediates cell proliferation and gene expression in the bladder epithelium association with activating protein-1 transactivation. Cancer Research, 60(13), 3445-53.
175. Smith, T.J., Crecelius, E.A. and Reading, J.C. (1977) Airborne arsenic exposure and excretion of methylated arsenic compounds. Environmental Health Perspectives, 19, 89-93.
176. Smith, M.S., Jones, P.R. and Shirachi, D.Y. (1992) The biomethylation of sodium arsenate by rat liver cytosol determined by mass spectrometry. Proceedings of the Western Pharmacology Society, 35, 53-55.
177. Smith, A.H., Lopipero, P.A., Bates, M.N. and Steinmaus, C.M. (2002) Arsenic epidemiology and drinking water standards. Science, 296(5576), 2145-46.
178. Spuches, A.M., Kruszyna, H.G., Rich, A.M. and Wilcox, D.E. (2005) Thermodynamics of the As(III)-thiol interaction: arsenite and monomethylarsenite complexes with glutathione, dihydrolipoic acid, and other thiol ligands. Inorganic Chemistry, 44(8), 2964-72.
179. Styblo, M., Del Razo, L.M., Vega, L. et al. (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Archives of Toxicology, 74(6), 289-99.
180. Styblo, M., Delnomdedieu, M. and Thomas, D.J. (1996) Mono-and dimethylation of arsenic in rat liver cytosol in vitro. Chemico-Biological Interactions, 99(1-3), 147-64.
181. Tam, G.K.H., Charbonneau, S.M. and Bryce, F. (1979) Metabolism of inorganic arsenic (74As) in humans following oral ingestion. Toxicology and Applied Pharmacology, 50(2), 319-22.
182. Tao, S.S.-H. and Bolger, P.M. (1999) Dietary arsenic intakes in the United States: FDA Total Diet Study, September 1991-December 1996. Food Additives and Contaminants, 16(8), 465-72.
183. Thomas, D.J. (2007) Molecular processes in cellular arsenic metabolism. Toxicology and Applied Pharmacology, 222(3), 365-73.
184. Thomas, D.J., Li, J., Waters, S.B. et al. (2007) Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Experimental Biology and Medicine, 232(1), 3-13.
185. Thomas, D.J., Styblo, M. and Lin, S. (2001) The cellular metabolism and systemic toxicity of arsenic. Toxicology and Applied Pharmacology, 176(2), 127-44.
186. Tsai, S.-M., Wang, T.-N. and Ko, Y.-C. (1999) Mortality for certain diseases in areas with high levels of arsenic in drinking water. Archives of Environmental Health, 54(3), 186-93.
187. Tseng, C.-H. (2005) Blackfoot disease and arsenic: A never-ending story. Journal of Environmental Science and Health-Part C Environmental Carcinogenesis and Ecotoxicology Reviews, 23(1), 55-74.
188. Tseng, W.P., Chu, H.M., How, S.W. et al. (1968) Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. Journal of the National Cancer Institute, 40(3), 453-63.
189. Tseng, C.-H., Huang, Y.-K., Huang, Y.-L. et al. (2005) Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicology and Applied Pharmacology, 206(3), 299-308.
190. Tseng, C.-H., Tai, T.-Y., Chong, C.-K. et al. (2000) Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: A cohort study in arseniasis-hyperendemic villages in Taiwan. Environmental Health Perspectives, 108(9), 847-51.
191. U.S. Environmental Protection Agency (US EPA) (1996) Bioavailability of Arsenic and Lead in Environmental Substrates. 1. Results of an Oral Dosing Study of Immature Swine. EPA 910/R-96-002, Superfund/Office of Environmental Assessment.
192. U.S. Food and Drug Administration (US FDA) (2005) Beverages: bottled water. Final rule. Federal Register, 66, 6976-7066.
193. Vahter, M. (1981) Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. Environmental Research, 25(2), 286-93.
194. Vahter, M. (2008) Health effects of early life exposure to arsenic. Basic and Clinical Pharmacology and Toxicology, 102(2), 204-11.
195. Vahter, M., Friberg, L. and Rahnster, B. (1986) Airborne arsenic and urinary excretion of metabolites of inorganic arsenic among smelter workers. International Archives of Occupational and Environmental Health, 57(2), 79-91.
196. Vahter, M. and Marafante, E. (1985) Reduction and binding of arsenate in marmoset monkeys. Archives of Toxicology, 57(2), 119-24.
197. 74As-dimethylarsinic acid in mice and rats. Archives of Environmental Contamination and Toxicology, 13(3), 259-64.
198. 74As-arsenite. Archives of Toxicology, 51(1), 65-77.
199. 74As-labeled trivalent and pentavalent inorganic arsenic in mice. Environmental Research, 21(2), 446-57.
200. Valenzuela, O.L., Borja-Aburto, V.H., Garcia-Vargas, G.G. et al. (2005) Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environmental Health Perspectives, 113(3), 250-54.
201. Vega, L., Styblo, M., Patterson, R. et al. (2001) Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicology and Applied Pharmacology, 172(3), 225-32.
202. Vijayaraghavan, M., Wanibuchi, H., Karim, R. et al. (2001) Dimethylarsinic acid induces 8-hydroxy-2'-deoxyguanosine formation in the kidney of NCI-Black-Reiter rats. Cancer Letters, 165(1), 11-17.
203. Waalkes, M.P., Liu, J. and Diwan, B.A. (2007) Transplacental arsenic carcinogenesis in mice. Toxicology and Applied Pharmacology, 222(3), 271-80.
204. Walton, F.S., Waters, S.B., Jolley, S.L. et al. (2003) Selenium compounds modulate the activity of recombinant rat AsIII-methyltransferase and the methylation of arsenite by rat and human hepatocytes. Chemical Research in Toxicology, 16(3), 261-65.
205. Wang, A., Holladay, S.D., Wolf, D.C. et al. (2006) Reproductive and developmental toxicity of arsenic in rodents: a review. International Journal of Toxicology, 25(5), 319-31.
206. Wang, C.-H., Hsiao, C.K., Chen, C.-L. et al. (2007) A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicology and Applied Pharmacology, 222(3), 315-26.
207. Wang, C.-H., Jeng, J.-S., Yip, P.-K. et al. (2002) Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation, 105(15), 1804-9.
208. Wanibuchi, H., Salim, E.I., Kinoshita, A. et al. (2004) Understanding arsenic carcinogenicity by the use of animal models. Toxicology and Applied Pharmacology, 198(3), 366-76.
209. Warren, H.V., Horksy, S.J. and Gould, C.E. (1983) Quantitative analysis of zinc, copper, lead, molybdenum, bismuth, mercury and arsenic in brain and other tissues from multiple sclerosis and non-multiple sclerosis cases. Science of the Total Environment, 29(1-2), 163-69.
210. Wasserman, G.A., Liu, X., Parvez, F. et al. (2004) Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environmental Health Perspectives, 112(13), 1329-33.
211. Wasserman, G.A., Liu, X., Parvez, F. et al. (2007) Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environmental Health Perspectives, 115(2), 285-89.
212. Waters, S.B., Devesa, V., Del Razo, L.M. et al. (2004a) Endogenous reductants support the catalytic function of recombinant rat Cyt19, an arsenic methyltransferase. Chemical Research in Toxicology, 17(3), 404-9.
213. Waters, S.B., Devesa, V., Fricke, M.W. et al. (2004b) Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase-catalyzed formation of trimethylarsine oxide and trimethylarsine. Chemical Research in Toxicology, 17(12), 1621-29.
214. Wei, M., Wanibuchi, H., Morimura, K. et al. (2002) Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis, 23(8), 1387-97.
215. Wester, R.C., Hui, X., Barbadillo, S. et al. (2004) In vivo percutaneous absorption of arsenic from water and CCA-treated wood residue. Toxicological Sciences, 79(2), 287-95.
216. Wester, R.C., Maibach, H.I., Sedik, L. et al. (1993) In vivo and in vitro percutaneous absorption and skin decontamination of arsenic from water and soil. Fundamental and Applied Toxicology, 20(3), 336-40.
217. Wildfang, E., Zakharyan, R.A. and Aposhian, H.V. (1998) Enzymatic methylation of arsenic compounds: VI. Characterization of hamster liver arsenite and methylarsonic acid methyltransferase activities in vitro. Toxicology and Applied Pharmacology, 152(2), 366-75.
218. World Health Organization (WHO) (1981) Arsenic. Environmental Health Criteria, Vol. 18, World Health Organization, International Programme on Chemical Safety, Geneva.
219. World Health Organization (WHO) (2001) Arsenic and Arsenic Compounds, Environmental Health Criteria, Vol. 224, 2nd edn, World Health Organization, International Programme on Chemical Safety, Geneva.
220. Wu, M.-M., Kuo, T.-L., Hwang, Y.-H. and Chen, C.-J. (1989) Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. American Journal of Epidemiology, 130(6), 1123-32.
221. Yager, J.W., Hicks, J.B. and Fabianova, E. (1997) Airborne arsenic and urinary excretion of arsenic metabolites during boiler cleaning operations in a Slovak coal-fired power plant. Environmental Health Perspectives, 105(8), 836-42.
222. Yamanaka, K., Hasegawa, A., Sawamura, R. and Okada, S. (1989) Dimethylated arsenics induce DNA strand breaks in lung via the production of active oxygen in mice. Biochemical and Biophysical Research Communications, 165(1), 43-50.
223. Yamanaka, K., Takabayashi, F., Mizoi, M. et al. (2001) Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis. Biochemical and Biophysical Research Communications, 287(1), 66-70.
224. Yamauchi, H. and Fowler, B.A. (1994) Toxicity and metabolism of inorganic and methylated arsenicals, in Arsenic in the Environment: Part II: Human Health and Ecosystem Effects (ed. J.O. Nriagu), John Wiley & Sons, Inc., New York, pp. 35-43.
225. Yamauchi, H., Takahashi, K., Mashiko, M. and Yamamura, Y. (1989) Biological monitoring of arsenic exposure of gallium arsenide-and inorganic arsenic-exposed workers by determination of inorganic arsenic and its metabolites in urine and hair. American Industrial Hygiene Association Journal, 50(11), 606-12.
226. Yamauchi, H. and Yamamura, Y. (1979) Dynamic change of inorganic arsenic and methylarsenic compounds in human urine after oral intake as arsenic trioxide. Industrial Health, 17(2), 79-83.
227. Yamauchi, H. and Yamamura, Y. (1983) Concentration and chemical species of arsenic in human tissue. Bulletin of Environmental Contamination and Toxicology, 31(3), 267-77.
228. Yamauchi, H. and Yamamura, Y. (1985) Metabolism and excretion of orally administered arsenic trioxide in the hamster. Toxicology, 34(2), 113-21.
229. Yang, C.-Y. (2006) Does arsenic exposure increase the risk of development of peripheral vascular diseases in humans? Journal of Toxicology and Environmental Health-Part A: Current Issues, 69(19), 1797-804.
230. Yang, J.-K., Barnett, M.O., Jardine, P.M. et al. (2002) Adsorption, sequestration, and bioaccessibility of As(V) in soils. Environmental Science and Technology, 36(21), 4562-69.
231. Yang, J.-K., Barnett, M.O., Zhuang, J. et al. (2005) Adsorption, oxidation, and bioaccessibility of As(III) in soils. Environmental Science and Technology, 39(18), 7102-10.
232. Yoshida, T., Yamauchi, H. and Fan Sun, G. (2004) Chronic health effects in people exposed to arsenic via the drinking water: Dose-response relationships in review. Toxicology and Applied Pharmacology, 198(3), 243-52.
233. Yu, H.-S., Lee, C.-H. and Chen, G.-S. (2002) Peripheral vascular diseases resulting from chronic arsenical poisoning. Journal of Dermatology, 29(3), 123-30.
234. Zakharyan, R.A. and Aposhian, H.V. (1999) Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase. Chemical Research in Toxicology, 12(12), 1278-83.
235. Zakharyan, R.A., Ayala-Fierro, F., Cullen, W.R. et al. (1999) Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMA(III)) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicology and Applied Pharmacology, 158(1), 9-15.
236. Zakharyan, R.A., Sampayo-Reyes, A., Healy, S.M. et al. (2001) Human monomethylarsonic acid (MMA (V)) reductase is a member of the glutathione-S-transferase superfamily. Chemical Research in Toxicology, 14(8), 1051-57.
237. Zakharyan, R., Wu, Y., Bogdan, G.M. and Aposhian, H.V. (1995) Enzymatic methylation of arsenic compounds: Assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chemical Research in Toxicology, 8(8), 1029-38.
238. Zhao, C.Q., Young, M.R., Diwan, B.A. et al. (1997) Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proceedings of the National Academy of Sciences of the United States of America, 94(20), 10907-912.